David Skale, MD
Ophthalmology · Wenatchee, WANPI 1568636462
Payments from drug & device makers
Across 7 payments — averaging $869.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec Digital Innovations LLC$6K
- AbbVie$65
- Notal Vision, Inc.$35
- Carl Zeiss Meditec AG$19
- Shire North American Group Inc$19
- Genentech USA, Inc.$18
- plus $16 from 1 others
What the payments were for
- Food & beverage$1543%
- Gifts$190%
- Other$5,91497%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec Digital Innovations LLC | 1 | $5,914 |
| AbbVie | 1 | $65 |
| Notal Vision, Inc. | 1 | $35 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Shire North American Group Inc | 1 | $19 |
| Genentech USA, Inc. | 1 | $18 |
| Alimera Sciences, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VERACITY SURGICAL$5,914
How this compares
$6,087 in reported general payments places this provider in the 80th percentile of 428 ophthalmology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 160 | $10,925 |
| Brimonidine Tartrate | 69 | $7,190 |
| Difluprednate | 23 | $4,997 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 25 | $4,535 |
| Dorzolamide Hcl | 100 | $1,822 |
| Ketorolac Tromethamine | 31 | $1,712 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 71 | $1,300 |
| ValacyclovirValacyclovir Hcl | 32 | $634 |
| Timolol Maleate | 38 | $564 |
| Latanoprost | 37 | $550 |
| Prednisone | 14 | $121 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Wenatchee
- Jonathan BriggsWenatchee$18K
- Michael McAllisterWenatchee$12K
- Robert WirthlinSpokane$2.4M
- Laura PerimanSeattle$1.9M
- Todd SchneidermanSilverdale$602K
- Sheldon CowenSeattle$560K
- Todd KlesertBellevue$506K
- Jason JonesSpokane$386K
- David SpinakSilverdale$351K
- Jay RuddPuyallup$291K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.